Nu Skin Enterprises, Inc. NUS is likely to display year-over-year declines in the top and bottom lines when it reports second-quarter 2022 earnings on Aug 4. The Zacks Consensus Estimate for revenues is pegged at $559.9 million, suggesting a decline of 20.5% from the prior-year quarter's reported figure.
Although the Zacks Consensus Estimate for earnings has moved 6.8% north over the past 30 days to 79 cents per share, it indicates a decrease of 31.3% from the figure reported in the prior-year period. In the last reported quarter, the company delivered an earnings surprise of 4.1%. The developer and distributor of personal care and wellness products has a trailing four-quarter earnings surprise of 10.6%, on average.
